TerrAscend (TSNDF) Exchange Rate Effect (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Exchange Rate Effect of $231000.0 for Q1 2026, up 1750.0% year-over-year from $12486.5 in Q1 2025, and up 247.13% quarter-over-quarter from -$157000.0 in Q4 2025.
TerrAscend (TSNDF) Exchange Rate Effect (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Exchange Rate Effect for 6 consecutive years, with $231000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 1750.0% year-over-year to $231000.0; the TTM figure through Mar 2026 stood at -$327000.0 (down 174.15% YoY), while the FY2025 annual figure was -$572000.0, down 187.6% from the prior year.
- Exchange Rate Effect improved to $231000.0 in Q1 2026 per TSNDF's latest filing, from -$157000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $951000.0 in Q4 2022 and bottomed at -$3.4 million in Q1 2022.
- Historically, Exchange Rate Effect has averaged -$161882.4 across 5 years, with a median of -$14000.0 in 2025.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect sank 192.19% — and 2026, when it jumped 1750.0%.
- TerrAscend's Exchange Rate Effect stood at $951000.0 in 2022, then tumbled by 115.14% to -$144000.0 in 2023, then surged by 360.42% to $375000.0 in 2024, then sank by 141.87% to -$157000.0 in 2025, then surged by 247.13% to $231000.0 in 2026.
- Business Quant data shows TSNDF's Exchange Rate Effect at $231000.0 in Q1 2026, -$157000.0 in Q4 2025, and -$224000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn | -38,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38,000.00 |
| Jun 30, 2026 | -38,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Sep 30, 2025 | -224,000.00 |
| Sep 30, 2025 | -224,000.00 |
| Jun 30, 2025 | -177,000.00 |
| Jun 30, 2025 | -177,000.00 |
| Mar 31, 2025 | -14,000.00 |
| Mar 31, 2025 | -14,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Sep 30, 2024 | -112,000.00 |
| Sep 30, 2024 | -112,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Mar 31, 2024 | 198,000.00 |